Engineered nanomedicine for myeloma and bone microenvironment targeting

Engineered nanomedicine for myeloma and bone microenvironment targeting

Bone is a favorable microenvironment for tumor growth and a frequent destination for metastatic cancer cells. Targeting cancers within the bone marrow remains a crucial oncologic challenge due to issues of drug availability and microenvironment-induced resistance. Herein, we engineered bone-homing p...

Full description

Bibliographic Details
Main Authors: Swami, Archana (Author), Reagan, Michaela R. (Author), Basto, Pamela Antonia (Contributor), Mishima, Yuji (Author), Kamaly, Nazila (Author), Glavey, Siobhan (Author), Zhang, Sufeng (Contributor), Moschetta, Michele (Author), Seevaratnam, Dushanth (Author), Zhang, Yong (Author), Liu, Jinhe (Author), Memarzadeh, Masoumeh (Author), Manier, Salomon (Author), Shi, Jinjun (Author), Bertrand, Nicolas (Contributor), Lu, Zhi Ning (Author), Nagano, Kenichi (Author), Baron, Roland (Author), Sacco, Antonio (Author), Roccaro, Aldo M. (Author), Farokhzad, Omid C. (Author), Ghobrial, Irene M. (Author), Wu, Jun 1968- (Author)
Other Authors: Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: National Academy of Sciences (U.S.), 2015-02-04T17:56:10Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items